CSL Ltd (OTC Pink - Current Information:CSLLY)

Data as of Sep 18
 +0.17 / +0.52%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

CSL Ltd. is engaged in the manufacturing and distributing of biopharmaceutical and allied products. The company's areas of expertise include plasma products, vaccines and pharmaceuticals and research and development. It operates through the following segments: CSL Behring, bioCSL and CSL Intellectual Property. The CSL Behring segment manufactures, markets and develops plasma therapies, which includes plasma products and recombinants. The bioCSL segment manufactures and distributes non-plasma biotherapeutic products. The CSL Intellectual Property segment licenses intellectual property to unrelated third parties. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia.

Contact Information

CSL Ltd.
45 Poplar Road
Parkville Victoria (vic) 3052
P:(139) 389-1911
Investor Relations:
(139) 389-2818



Other institutional0.14%
Mutual fund holders0.00%
Individual stakeholders--

Top Executives

Paul Roger PerreaultChief Executive Officer, Executive Director & MD
Gordon NaylorChief Financial Officer
Andrew CuthbertsonChief Scientific Officer
Mark DehringDirector-Investor Relations
Sharon McHaleSenior Director-Public Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.